As of April 29, 2025, Xilio Therapeutics (XLO) has a market cap of $39.136 million USD. According to our data, Xilio Therapeutics is ranked No.8253 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $39.14 M |
-10.36%
|
Dec 31, 2024 | $43.66 M |
73.64%
|
Dec 29, 2023 | $25.14 M |
-79.55%
|
Dec 30, 2022 | $0.12 B |
-83.19%
|
Dec 31, 2021 | $0.73 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
![]() Merck
MRK
|
$212.01 B |
-0.001 M
|
![]() USA
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.59 B |
0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.76 B |
0.000 M
|
![]() USA
|
![]() Novartis
NVS
|
$224.23 B |
0.160 B
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
![]() AstraZeneca
AZN
|
$222.30 B |
0.004 M
|
![]() UK
|
![]() Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$342.32 B |
-0.001 M
|
![]() USA
|
Market Cap | = | XLO Stock Price | * | XLO Shares Outstanding |
= | $0.76 | * | 51.77 M | |
= | $39.14 M |